Article Text

AB0119 Fully Human Monoclonal Antibodies to Phosphorylcholine Inhibit Basal and Tnf-Induced IL-6 and ICAM-1 in Synovial-Like Fibroblasts from A Rheumatoid Arthritis
  1. D. Thiagarajan1,
  2. V. Malmstrom2,
  3. J. Frostegård1,
  4. R. Fiskesund1,
  5. J. Steen2,
  6. A. Frostegård1
  1. 1IMM; Unit of Immunology and Chronic Disease, Karolinska Institutet
  2. 2CMM, Department of MEdicine, Solna, Karolinska Institutet, Stockholm, Sweden


Background Recently, we described that non-responders to anti-TNF therapy in rheumatoid arthritis (RA) had significantly lower levels of antibodies targeting phsphorylcholine (anti-PC)

Since we had observed anti-inflammatory properties of human polyclonal anti-PC vitro, we generated a panel of fully human monoclonal antibodies to PC (anti-PC mAbs).

Objectives In this study we aimed at investigating effect of anti-PC mAbs on basal and TNF-induced IL-6 secretion and ICAM-1 expression in synovial-like fibroblasts from a healthy and a RA donor.

Methods Fully human monoclonal antibodies targeting PC of IgG1 isotype were generated from healthy human donors via single-cell sorting of PC-reactive B-cells and consequent cloning/production in human embryonic kidney (HEK) cell system. Synovial-like fibroblasts from a healthy and a RA donor at passage 3 were cultured under serum-free conditions for 12 hrs, pre-incubated with 2 clones of anti-PC mAbs (A01 and E01) at 5 μg/ml for 1 hr. TNF was added at 10 ng/ml. IL-6 levels in cell culture supernatants were measured after 12 hrs by high-sensitivity commercial ELISA. ICAM-1 and VCAM-1 was analysed by flow cytomery.

Results A significant decrease in both basal and TNF-induced IL-6 level in cell supernatants of RA synoviocyte-like fibroblasts was observed with anti-PC mAbs Simultaneously, a significant decrease in surface expression of both ICAM-1 and VCAM-1 was observed. Anti PC mAbs excerted similar effect on TNF-induced Il-6 adn ICAM- 1 expression in healthy synoviocytes.

Conclusions Fully human anti-PC mAbs could be produced by single-cell sorting of PC-reactive B-cells and consequent cloning/production in a human cell system. Anti-PC mAbs inhibit both basal and TNF-induced IL-6 levels in cultured synoviocyte-like fibroblasts from rheumatoid arthrtis. Further, there was a variation in the effects between clones. Our data suggest that anti PC mAbs could be of therapeutic interest.

Disclosure of Interest D. Thiagarajan: None declared, V. Malmstrom: None declared, J. Frostegård Shareholder of: JF is named as co-inventor in patents/patent applications in relation to anti-PC, R. Fiskesund Shareholder of: RF is named as a co inventor on a pending patent application in rleation to anti OC mAbs, J. Steen: None declared, A. Frostegård Shareholder of: AF is named as a co-inventor in pending patent application in relation to anti PC

DOI 10.1136/annrheumdis-2014-eular.6090

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.